Tag: NYSE:TEVA

April 17, 2020

5 Top Pharmaceutical ETFs

A wide range of investors may want to consider pharmaceutical ETFs as a way to stay informed about and invest...
February 12, 2020

Teva Reports Fourth Quarter and Full Year 2019 Financial Results

Teva Pharmaceutical reported US$16.9 billion in full year revenue in its results for the year and the quarter ended December...
October 2, 2019

GlaxoSmithKline Files NDA for Inhaler to Treat Asthma

The company's inhaler therapy, Trelegy Ellipta, has already been approved in the US for chronic obstructive pulmonary disease.
September 16, 2019

Lundbeck to Buy Alder BioPharma in US$2 Billion Deal

Lundbeck will add Alder BioPharma's potential blockbuster migraine treatment, eptinezumab, to its pipeline ahead of patent expirations.